Skip to main content
Tweets by AES2020
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Better Outcomes through Diveristy
Pediatric Highlights Poster
Partners Against Mortality in Epilepsy
Louis Ferrari, RPh. MBA
SK Life Science, Inc.
(334) Post-hoc Analysis of a Phase 3, Open-Label Study of Cenobamate for Treatment of Uncontrolled Focal Seizures: Effects of Dose Reductions to Concomitant Lamotrigine and Carbamazepine
Sunday, December 6, 2020
12:00 PM – 1:30 PM US EST